Atlas Trials

Can Contrast Enhanced Spectral Mammography (CESM) Reduce the Number of Benign Biopsies for Calcifications Without Negatively Impacting on Detection/Diagnosis of Clinically Significant Calcifications

Clinical trial NCT03857152 · UNKNOWN

Trial details

NCT number
NCT03857152
Sponsor
The Leeds Teaching Hospitals NHS Trust
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Mammography
Start date
2018-12-03
Primary completion
2021-02-02
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.